Shaping the Future Together: UniWerk Is the winning project of the Freiburg Unicorn Fund

A mobile participation format prevails in the University’s Unicorn Fund initiative. UniWerk was selected as the winner from among 35 strong ideas. As part of Freiburg’s proposal in the Excellence Strategy, it could provide impetus for innovation and transformation across the University from 2027 on.

New therapeutic approach for rare childhood brain disease

Freiburg physicians show for the first time that immune cells in the brain are involved in the disposal of metabolic products

Taking the fight against colorectal cancer from the lab to a start-up

If you combine top-level research and entrepreneurial spirit, you can generate positive effects for society and business. That’s the premise of the University of Freiburg spin-off EMUNO Therapeutics GmbH, founded by Dr. Emilia Neuwirt and Prof. Dr. Olaf Groß.

Targeted activation of brain immune cells delays Alzheimer's processes

Study in an animal model shows how the brain's own immune cells react in Alzheimer's disease. Freiburg researchers identify an important signaling pathway. The study was published in Nature Neuroscience.

Molecular arms race: How the genome defends itself against internal enemies

An international research team has deciphered a mechanism of evolutionary arms race in human cells.

Prof. Dr. Ibrahim Cissé elected EMBO member

Recognition for outstanding achievements in the life sciences for Max Planck Director and CIBSS researcher

Extended funding for research training group "ProtPath"

The German Research Foundation (DFG) has approved funding for the establishment of two new research training groups and the extension of one existing research training group at the University of Freiburg.

Simon Elsässer has been appointed as an Alexander von Humboldt Professor

Biochemist Prof. Dr. Simon Elsässer will receive five years of funding to strengthen and expand the key research area “Signals of Life” at the University of Freiburg.

Open Now: Recruitment of new cohort of Freiburg Rising Stars Academy

CIBSS invites PhD students and postdoctoral researchers worldwide to apply for collaborating with one of the CIBSS-host-PIs during a research stay in Freiburg.

Deadline for applications: 15 July 2025.

CIBSS has acquired renewed funding to spearhead next-generation integrative signalling research at the University of Freiburg

On 22 May 2025, the Excellence Commission announced its positive funding decision for CIBSS. This major boost to biological signalling research reinforces CIBSS’s role as a leading centre for basic life science research and innovation.